Prevalence of Osteoporosis in Patients Who Uses Inhaled Steroids

Not Applicable

• Conditions: Osteoporosis

• Registration Number: NCT01246375
• Lead Sponsor: Tel-Aviv Sourasky Medical Center

Brief Summary

The purpose of this research is to determine whether the prevalence of osteoporosis is greater in patients who suffer from Chronic obstructive pulmonary disease (COPD) or Asthma disease and uses inhaled steroids.

Detailed Description

Not available

Study Timeline

• Status Verified: 2010-11
• Study First Submitted: 2010-11-21
• Study First Submitted QC: 2010-11-22
• Study First Posted: 2010-11-23
• Last Update Submitted: 2010-11-24
• Last Update Posted: 2010-11-25
• Study Start: 2010-12
• Primary Completion: 2011-12
• Study Completion: 2011-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

1. Man at the minimum age of 60 years.
2. Diagnosed with Chronic Obstructive Pulmonary disease (COPD) or Asthma disease.
3. Usage of the following corticosteroids at the minimal doses indicated, for at least 3 years:

Seretide 250/50 mcg Symbicort 320/9 mcg 5.No Diagnosis of thyroid irregularity 6.No diagnosis/treatment for Osteoporosis.

Exclusion Criteria

1. Usage of systemic steroids more than once during the 12 months prior to the study.
2. Usage of systemic steroids during the month prior to the study.
3. Usage of inhaled steroids in order to treat any other disease except Chronic Obstructive Pulmonary Disease (COPD) or Asthma.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Diagnosis of Osteoporosis	3

Trial Locations

Locations (1)

Tel Aviv medical center; 🇮🇱 Tel Aviv, Israel